Riociguat for the treatment of pulmonary arterial hypertension (PAH): A responder analysis from the phase III PATENT-1 study

被引：0
|
作者：
Gruenig, Ekkehard [1 ]
Galie, Nazzareno [2 ]
Humbert, Marc [3 ,4 ,5 ]
Keogh, Anne M. [6 ]
Langleben, David [7 ]
Rubin, Lewis J. [8 ]
Speich, Rudolf [9 ]
Fritsch, Arno [10 ]
Davie, Neil [10 ]
Ghofrani, Hossein-Ardeschir [11 ,12 ]
机构：
[1] Univ Heidelberg Hosp, Thoraxclin, Thoraxclin Heidelberg, Ctr Pulm Hypertens, Heidelberg, Germany
[2] Univ Bologna, Inst Cardiol, Bologna, Italy
[3] Univ Paris 11, Le Kremlin Bicetre, France
[4] INSERM, F-94275 Le Kremlin Bicetre, France
[5] Hop Bicetre, AP HP, Serv Pneumol, Le Kremlin Bicetre, France
[6] St Vincents Hosp, Heart Lung Transplant Unit, Sydney, NSW 2010, Australia
[7] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Ctr Pulm Vasc Dis, Montreal, PQ H3T 1E2, Canada
[8] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA
[9] Univ Zurich Hosp, Dept Internal Med, Zurich, Switzerland
[10] Bayer HealthCare Pharmaceut, Global Clin Dev, Wuppertal, Germany
[11] Univ Giessen, Dept Internal Med, Giessen, Germany
[12] Marburg Lung Ctr UGMLC, Giessen, Germany
来源：
EUROPEAN RESPIRATORY JOURNAL | 2013年 / 42卷
关键词：
Pulmonary hypertension; Treatments; Nitric oxide;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2347
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Correlation of improvements in hemodynamics and exercise capacity in patients with PAH: Results from the phase III PATENT-1 study
    Galie, Nazzareno
    Grimminger, Friedrich
    Gruenig, Ekkehard
    Humbert, Marc
    Jing, Zhi-Cheng
    Keogh, Anne M.
    Langleben, David
    Rubin, Lewis J.
    Kilama, Michael Ochan
    Fritsch, Arno
    Davie, Neil
    Ghofrani, Hossein-Ardeschir
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [22] Riociguat in children with pulmonary arterial hypertension: The PATENT-CHILD study
    Aguilar, Humberto Garcia
    Gorenflo, Matthias
    Ivy, D. Dunbar
    Moledina, Shahin
    Castaldi, Biagio
    Ishida, Hidekazu
    Kusa, Jacek
    Miera, Oliver
    Pattathu, Joseph
    Weng, Ken-Pen
    Ablonczy, Laszlo
    Apitz, Christian
    Katona, Marta
    Kurosaki, Kenichi
    Pulido, Tomas
    Yamagishi, Hiroyuki
    Yasuda, Kazushi
    Cisternas, Galia
    Goth, Melanie
    Lippert, Susanne
    Radomskyj, Anna
    Saleh, Soundos
    Willmann, Stefan
    Wirsching, Gabriela
    Bonnet, Damien
    Beghetti, Maurice
    Czegniewicz, Pawel
    PULMONARY CIRCULATION, 2022, 12 (03)
  • [23] Riociguat for the treatment of pulmonary arterial hypertension (PAH): 2-year results from the PATENT--2 long-term extension
    Rubin, Lewis J.
    Galie, Nazzareno
    Grimminger, Friedrich
    Granig, Ekkehard
    Humbert, Marc
    Jing, Zhi-Cheng
    Keogh, Anne
    Langleben, David
    Fritsch, Arno
    Menezes, Flavia
    Davie, Neil
    Ghofrani, Hossein-Ardeschir
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [24] Reduction In Nt-Probnp And Its Association With Clinical Status In Patients With Pah: Results From The Patent-1 Study With Riociguat
    Torbicki, A.
    Galie, N.
    Ghofrani, H. A.
    He, J.
    Huang, Y.
    Keogh, A. M.
    Langleben, D.
    Rubin, L. J.
    Zhou, D.
    Davie, N.
    Fritsch, A.
    Humbert, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [25] Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study
    Ghofrani, H. A.
    Hoeper, M. M.
    Halank, M.
    Meyer, F. J.
    Staehler, G.
    Behr, J.
    Ewert, R.
    Weimann, G.
    Grimminger, F.
    EUROPEAN RESPIRATORY JOURNAL, 2010, 36 (04) : 792 - 799
  • [26] Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2)
    Rubin, Lewis J.
    Galie, Nazzareno
    Grimminger, Friedrich
    Gruenig, Ekkehard
    Humbert, Marc
    Jing, Zhi-Cheng
    Keogh, Anne
    Langleben, David
    Fritsch, Arno
    Menezes, Flavia
    Davie, Neil
    Ghofrani, Hossein-Ardeschir
    EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (05) : 1303 - 1313
  • [27] Riociguat for the treatment of inoperable CTEPH or persistent/recurrent PH after pulmonary endarterectomy (PEA): A responder analysis from the phase III CHEST-1 study
    D'Armini, Andrea M.
    Ghofrani, Hossein-Ardeschir
    Kim, Nick H.
    Mayer, Eckhard
    Simonneau, Gerald
    Wilkins, Martin R.
    Pulido, Tomas
    Fritsch, Arno
    Davie, Neil
    Hoeper, Marius M.
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [28] Riociguat for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH): Final data from a phase II long-term extension (LTE) study
    Hoeper, Marius
    Ghofrani, Hossein-Ardeschir
    Halank, Michael
    Meyer, F. Joachim
    Staehler, Gerd
    Behr, Juergen
    Ewert, Ralf
    Fletcher, Monique
    Colorado, Pablo
    Nikkho, Sylvia
    Pena, Janethe de Oliveira
    Grimminger, Friedrich
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [29] Long-term Riociguat Treatment in PAH Patients in WHO Functional Class (FC) I/II Versus FC III/IV at Baseline: Results From the 12-Week Phase III PATENT-1 Study and PATENT-2 Open-Label Extension
    Meyer, Gisela
    Galie, Nazzareno
    Grimminger, Friedrich
    Gruenig, Ekkehard
    Humbert, Marc
    Jing, Zhi-Cheng
    Keogh, Anne M.
    Langleben, David
    Rubin, Lewis J.
    Fritsch, Arno
    Davie, Neil
    Ghofrani, Hossein-Ardeschir
    CHEST, 2014, 145 (03)
  • [30] PATENT PLUS: a blinded, randomised and extension study of riociguat plus sildenafil in pulmonary arterial hypertension
    Galie, Nazzareno
    Mueller, Katharina
    Scalise, Andrea-Viviana
    Gruenig, Ekkehard
    EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (05) : 1314 - 1322
12345